Saturday, June 07, 2025 | 08:54 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Price is the key growth driver of Indian pharma market, shows AWACS data

Market set to grow by 2.5-5% in calendar 2022. could even hit 5% due to a strong seasonal sales such as anti-infectives, and impact of NLEM drugs price hike

pharma
premium

Sohini Das Mumbai
Price growth is the major growth driver of the Indian pharma market, shows data from market research firm AWACS.

With a 10 per cent hike allowed for scheduled drugs (under price control) according to the wholesale price inflation this year, price hikes are likely to continue over the next 12-months gradually, and thus AWACS expects the Indian Pharma Market (IPM) to clock a 2.5 per cent growth in calendar 2022.

With a strong seasonal sales of anti-infectives and some other categories, impact of the NLEM (National List of Essential Medicines) drugs price hike may take the market growth to 5